Compare VCEL & AHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VCEL | AHCO |
|---|---|---|
| Founded | 1989 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | 1996 | 2017 |
| Metric | VCEL | AHCO |
|---|---|---|
| Price | $35.76 | $12.93 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | ★ $57.75 | $13.50 |
| AVG Volume (30 Days) | 557.8K | ★ 1.2M |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.00 | N/A |
| EPS | ★ 0.32 | N/A |
| Revenue | $276,259,000.00 | ★ $3,244,857,000.00 |
| Revenue This Year | $19.40 | $9.00 |
| Revenue Next Year | $18.24 | $6.93 |
| P/E Ratio | $106.89 | ★ N/A |
| Revenue Growth | ★ 16.45 | N/A |
| 52 Week Low | $28.95 | $7.91 |
| 52 Week High | $45.97 | $12.87 |
| Indicator | VCEL | AHCO |
|---|---|---|
| Relative Strength Index (RSI) | 57.65 | 67.91 |
| Support Level | $34.26 | $8.72 |
| Resistance Level | $38.48 | N/A |
| Average True Range (ATR) | 1.31 | 0.42 |
| MACD | 0.18 | -0.02 |
| Stochastic Oscillator | 94.02 | 96.80 |
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company operates under four reportable segments that align with its product categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home. The company generates majority of its revenue from the Sleep Health segment. The Sleep Health segment provides sleep therapy equipment, supplies and related services (including continuous positive airway pressure and BiLevel services) to individuals for the treatment of obstructive sleep apnea.